Discover 1,443 paid clinical trials in St. Petersburg, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,443
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function
for
Hepatic Impairment, Healthy
Location: Tampa FL, Orlando FL, Lake Forest CA
Sponsor: Pfizer
Sex: All
Age: 18 - 70+
Code: NCT07269301
Phase1, Recruiting
A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in People With Normal Liver Function and Different Levels of Liver Disease
Location: Tampa FL, Cape Coral FL, Winter Park FL, Wellington FL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06875973
Phase3, Recruiting
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa (HS)
Location: Tampa FL, Boca Raton FL, Fort Lauderdale FL,
Sponsor: Bluefin Biomedicine, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07287644
Phase2, Phase3, Recruiting
A Study of NTX-1472 in Social Anxiety Disorder
for
Social Anxiety Disorder (SAD)
Location: Tampa FL, Jacksonville FL, Memphis TN, Austin TX,
Sponsor: Newleos Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT07323784
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Tampa FL, Jacksonville FL, Miami FL, Macon GA,
Sponsor: LEO Pharma
Sex: All
Age: 0 - 11
Code: NCT06311682
Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
for
Myasthenia Gravis
Location: Clearwater FL, Greenville SC, New Bern NC,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07673744
Phase2, Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)